Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19. Poonam PBH, Koscik R, Nguyen T, Rikhi S, et al. PLoS One 2022;17:e0270646.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Poonam PBH, Koscik R, Nguyen T, Rikhi S, et al. Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19. PLoS One 2022;17:e0270646.
PMID: 35759496